HomeCompareGMVD vs EPRT

GMVD vs EPRT: Dividend Comparison 2026

GMVD yields 1089.92% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GMVD wins by $40079029.53M in total portfolio value
10 years
GMVD
GMVD
● Live price
1089.92%
Share price
$0.18
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40079029.59M
Annual income
$33,951,292,043,630.05
Full GMVD calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — GMVD vs EPRT

📍 GMVD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGMVDEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GMVD + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GMVD pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GMVD
Annual income on $10K today (after 15% tax)
$92,643.05/yr
After 10yr DRIP, annual income (after tax)
$28,858,598,237,085.54/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, GMVD beats the other by $28,858,598,226,170.92/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GMVD + EPRT for your $10,000?

GMVD: 50%EPRT: 50%
100% EPRT50/50100% GMVD
Portfolio after 10yr
$20039514.83M
Annual income
$16,975,646,028,235.38/yr
Blended yield
84.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

GMVD
No analyst data
Altman Z
-49.7
Piotroski
5/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GMVD buys
0
EPRT buys
0
No recent congressional trades found for GMVD or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGMVDEPRT
Forward yield1089.92%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$40079029.59M$63.4K
Annual income after 10y$33,951,292,043,630.05$12,840.73
Total dividends collected$39616262.31M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: GMVD vs EPRT ($10,000, DRIP)

YearGMVD PortfolioGMVD Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$119,692$108,991.83$11,205$505.18+$108.5KGMVD
2$1,347,269$1,219,199.12$12,672$682.46+$1.33MGMVD
3$14,267,270$12,825,692.08$14,490$930.48+$14.25MGMVD
4$142,201,592$126,935,612.66$16,786$1,282.69+$142.18MGMVD
5$1,334,552,582$1,182,396,878.44$19,753$1,791.56+$1334.53MGMVD
6$11,798,734,713$10,370,763,450.59$23,677$2,541.64+$11798.71MGMVD
7$98,313,966,328$85,689,320,184.54$29,008$3,672.99+$98313.94MGMVD
8$772,498,365,269$667,302,421,298.29$36,463$5,425.08+$772498.33MGMVD
9$5,726,857,521,661$4,900,284,270,823.10$47,238$8,221.57+$5726857.47MGMVD
10$40,079,029,591,807$33,951,292,043,630.05$63,385$12,840.73+$40079029.53MGMVD

GMVD vs EPRT: Complete Analysis 2026

GMVDStock

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.

Full GMVD Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this GMVD vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GMVD vs SCHDGMVD vs JEPIGMVD vs OGMVD vs KOGMVD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.